Safe and effective management of the obese patient

Mayo Clinic Proceedings

Volumn 74, Issue 12, 1999, Pages 1255-1260

  Collazo Clavell, Maria L ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE;

BARIATRIC SURGERY; DIET THERAPY; DYSLIPIDEMIA; EXERCISE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW;

EID: 0032738666     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.12.1255     Document Type: Review

References (12)

1. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report [published correction appears in ObesRes. 1998;6:464]. Obes Res. 1998;6(suppl 2):51S-209S.
2. Pi-Sunyer EX. Medical hazards of obesity. Ann Intern Med. 1993:119:655-660.
3. Agras WS, Teich CF, Arnow B, Eldredge K, Marnell M. One-year follow-up of cognitive-behavioral therapy for obese individuals with binge eating disorder. J Consult Clin Psychol. 1997;65:343-347.
4. Zelasko CJ. Exercise for weight loss: what are the facts? y Am Diet Assoc. 1995;95:1414-1417.
5. Levine JA, Eberhard! NL, Jensen MD. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science. 1999;283:212-214.
6. Brownell KD. The Learn Program for Weight Control. Dallas, Tex: American Health Publishing Co; 1997.
7. Lean ME. Sibutramine-a review of clinical efficacy. Int J Obes Relat Metab Disord. 1997;21(suppl 1):S30-S36.
8. Meridia (orlistat). In: 1999 Physicians' Desk Reference. Montvale, NJ: Medical Economics Data Production Co; 1998:1494-1498.
9. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999;281:235-242.
10. Sjostrb'm L, Rissanen A, Andersen T, et al, European Multicentre Orlistat Study Group. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998;352:167-173.
11. Greeno CG, Wing RR. A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder. Am J Clin Nutr. 1996;64:267273.
12. Balsinger BM, Luque-de Leon E, Sarr MG. Surgical treatment of obesity: who is an appropriate candidate? Mayo Clin Proc. 1997; 72:551-558.